Group 1 - The core viewpoint of the article highlights the performance of the E Fund Hong Kong Stock Connect Innovative Drug ETF (159316), which experienced a decline of 3.52% on February 2, with a trading volume of 355 million yuan [1] - The fund's total shares increased by 10 million to reach 3.188 billion, with a total increase of 40 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 4.03 billion yuan, and its performance benchmark is the Hang Seng Hong Kong Stock Connect Innovative Drug Index return rate [1] Group 2 - Since its establishment on March 18, 2025, the fund has achieved a return of 26.41%, while its return over the past month has been -0.05% [1] - The fund is managed by E Fund Management Co., Ltd., with fund managers Cheng Xi and Xiao Wanyuan [1]
2月2日港股通创新药ETF易方达（159316）份额增加1000.00万份
Xin Lang Cai Jing·2026-02-03 01:09